Lack of CRP response in patients with active rheumatoid arthritis

  • Research type

    Research Study

  • Full title

    Lack of CRP response in patients with active rheumatoid arthritis, as defined by ultrasound evidence of synovitis - What are the clinical implications and immunological causes?

  • IRAS ID

    160142

  • Contact name

    Jessica Manson

  • Contact email

    jessica.manson@uclh.nhs.uk

  • Sponsor organisation

    University College London Hospitals NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    WI190882, Pfizer Tracking Number ; Z6364106/2014/07/45, UCL Data Protection Registration, reference No

  • Research summary

    Rheumatologist-led musculoskeletal ultrasound clinics are used increasingly to assess for joint erosions and disease activity in patients with rheumatoid arthritis (RA). Using this technique we have identified an atypical subgroup of RA patients who have active disease demonstrated on the scan, but do not have elevated inflammation levels in the blood (C-reactive protein (CRP) levels). We questioned whether this unusual presentation was associated with either a delay in diagnosis or in relative under treatment, risking worse disease outcome and disability. This project aims to define this subpopulation of RA patients both clinically and immunologically. Specifically, RA patients with active disease, confirmed on ultrasound, will be divided into two groups depending upon whether they have normal or raised CRP levels. We will compare the clinical features of these two patient groups with particular attention to erosion accrual and drug history; analyse their serum and cellular immunological markers and correlate the immunological findings with clinical characteristics and disability scores. By investigating the immunological markers, and comparing this to the clinical features, we aim to identify a specific signature or ‘barcode’ that can be used to identify patients that need more aggressive treatment despite having a normal CRP response. Thus this study, originating from a clinical observation, will provide important information that could directly impact patient care.

  • REC name

    London - Hampstead Research Ethics Committee

  • REC reference

    14/LO/1506

  • Date of REC Opinion

    19 Aug 2014

  • REC opinion

    Favourable Opinion